Followers | 505 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
![](https://investorshub.advfn.com/uicon/475374.png?cb=1683825270)
Saturday, December 02, 2017 1:55:42 PM
bull flag
inverted head and shoulders bottom
DanDrit Biotech USA, Inc.
U.S. Office
375 Park Avenue, Suite 2607
New York, NY, 10152
United States
Phone: +1 (212) 763 0184
Danish Office
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark
Lab Facilities
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark
http://www.dandrit.com
https://mytomorrows.com/en/
DanDrit Biotech USA, Inc. is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. DanDrit Biotech A/S was founded in 2001 on the research of Professor Jesper Zeuthen at the Danish Cancer Society (Kraeftens Bekaempelse). Dendritic cells are critical components of the immune system. The ability of dendritic cells to induce a strong immune response is the basis of the vaccine therapies under development at DanDrit. Our expertise in producing dendritic cells from a patient’s blood is combined with conventional production methods to make new and advanced vaccines for cancer patients.
The proprietary technology upon which MCV is based is protected by several issued patents.
Also based on a 2011 Nobel Prize for research on dendritic cells.
normal chart
log chart
Recent RENB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 09:44:16 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 07/19/2024 09:40:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:32:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 12:46:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 08:50:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 10:38:41 PM
- Renovaro, Inc. Announces $10 million in Equity Committed • GlobeNewswire Inc. • 06/14/2024 01:06:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/11/2024 03:29:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2024 07:52:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 01:35:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:33:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 02:19:01 PM
- Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy • GlobeNewswire Inc. • 05/24/2024 01:20:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/18/2024 01:37:53 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM